Patents by Inventor Sujit Basu

Sujit Basu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230414698
    Abstract: The present disclosure relates to compositions comprising collagen 7 and methods of using the same to treat DEB.
    Type: Application
    Filed: February 15, 2023
    Publication date: December 28, 2023
    Inventors: Igor QUINONES-GARCIA, Lin Guey, Kris Lowe, Vinh Nguyen, Bing He, Amey Bandekar, Sujit Basu
  • Publication number: 20200316158
    Abstract: The present disclosure relates to compositions comprising collagen 7 and methods of using the same to treat DEB.
    Type: Application
    Filed: May 15, 2020
    Publication date: October 8, 2020
    Inventors: Igor Quinones-Garcia, Lin Guey, Kris Lowe, Vinh Nguyen, Bing He, Amey Bandekar, Sujit Basu
  • Publication number: 20200237883
    Abstract: The present invention provides, among other things, compositions and methods for CNS delivery of lysosomal enzymes (e.g., recombinant human arylsulfatase A (rhASA)) for effective treatment of lysosomal storage diseases (e.g., Metachromatic Leukodystrophy Disease). In some embodiments, the present invention includes a stable formulation for intrathecal administration comprising an ASA protein and a poloxamer, wherein less than 5% of the ASA protein exists in aggregated form.
    Type: Application
    Filed: April 17, 2020
    Publication date: July 30, 2020
    Inventors: Nazila Salamat-Miller, Katherine Taylor, Paul Campolieto, Zahra Shahrokh, Jing Pan, Lawrence Charnas, Teresa Leah Wright, Pericles Calias, Keethkumar Jain, Sujit Basu
  • Patent number: 10695395
    Abstract: The present disclosure relates to compositions comprising collagen 7 and methods of using the same to treat DEB.
    Type: Grant
    Filed: December 21, 2016
    Date of Patent: June 30, 2020
    Assignee: PHOENIX TISSUE REPAIR, INC.
    Inventors: Igor Quinones-Garcia, Lin Guey, Kris Lowe, Vinh Nguyen, Bing He, Amey Bandekar, Sujit Basu
  • Patent number: 10660944
    Abstract: The present invention provides, among oilier things, compositions and methods for CNS delivery of lysosomal enzymes (e.g., recombinant human arylsulfatase A (rhASA)) for effective treatment of lysosomal storage diseases (e.g. Metachromatic Leukodystrophy Disease), In some embodiments, the present invention includes a stable formulation for intrathecal administration comprising an ASA protein and a poloxamer, wherein less than 3% of the ASA protein exists in aggregated form.
    Type: Grant
    Filed: June 5, 2018
    Date of Patent: May 26, 2020
    Assignee: Shire Human Genetic Therapies, Inc.
    Inventors: Nazila Salamat-Miller, Katherine Taylor, Paul Campolieto, Zahra Shahrokh, Jing Pan, Lawrence Charnas, Teresa Leah Wright, Pericles Calias, Keethkumar Jain, Sujit Basu
  • Publication number: 20190125841
    Abstract: The present invention provides, among oilier things, compositions and methods for CNS delivery of lysosomal enzymes (e.g., recombinant human arylsulfatase A (rhASA)) for effective treatment of lysosomal storage diseases (e.g. Metachromatic Leukodystrophy Disease), In some embodiments, the present invention includes a stable formulation for intrathecal administration comprising an ASA protein and a poloxamer, wherein less than 3% of the ASA protein exists in aggregated form.
    Type: Application
    Filed: June 5, 2018
    Publication date: May 2, 2019
    Inventors: Nazila Salamat-Miller, Katherine Taylor, Paul Campolieto, Zahra Shahrokh, Jing Pan, Lawrence Charnas, Teresa Leah Wright, Pericles Calias, Keethkumar Jain, Sujit Basu
  • Publication number: 20190000912
    Abstract: The present disclosure relates to compositions comprising collagen 7 and methods of using the same to treat DEB.
    Type: Application
    Filed: December 21, 2016
    Publication date: January 3, 2019
    Inventors: Igor Quinones-Garcia, Lin Guey, Kris Lowe, Vinh Nguyen, Bing He, Amey Bandekar, Sujit Basu
  • Publication number: 20140377244
    Abstract: The present invention provides, among oilier things, compositions and methods for CNS delivery of lysosomal enzymes (e.g., recombinant human arylsulfatase A (rhASA)) for effective treatment of lysosomal storage diseases (e.g. Metachromatic Leukodystrophy Disease). In some embodiments, the present invention includes a stable formulation for intrathecal administration comprising an ASA protein and a poloxamer, wherein less than 3% of the ASA protein exists in aggregated form.
    Type: Application
    Filed: December 21, 2012
    Publication date: December 25, 2014
    Inventors: Nazila Salamat-Miller, Katherine Taylor, Paul Campolieto, Zahra Shahrokh, Jing Pan, Lawrence Charnas, Teresa Leah Wright, Pericles Calias, Keethkumar Jain, Sujit Basu
  • Publication number: 20050138606
    Abstract: One disclosed method for converting data suitable for use on a source platform into data suitable for use on a target platform comprises analyzing source platform code; extracting information from the analyzed source platform code wherein the extracted information includes at least the logic, flow, user interface description, and data of the source platform code; defining a generic data structure and format for storing the extracted information; storing the extracted information in the defined structure and format; and transforming the extracted information into code suitable for the target platform wherein the transforming step comprises transforming the extracted information into code suitable for the target platform after the extracted information is stored in the defined structure and format.
    Type: Application
    Filed: December 17, 2003
    Publication date: June 23, 2005
    Inventors: Sujit Basu, Khalid Beg, Bruno Chartier, Ted Chau, Cheok Chu
  • Publication number: 20050003003
    Abstract: Particles which include a bioactive agent are prepared to have a desired matrix transition temperature. Delivery of the particles via the pulmonary system results in modulation of drug release from the particles. Sustained release and/or sustained pharmacologic action of the drug can be obtained by forming particles which include a combination of phospholipids that are miscible in one another and have a high matrix transition temperature.
    Type: Application
    Filed: April 28, 2003
    Publication date: January 6, 2005
    Applicant: Advanced Inhalation Research, Inc.
    Inventors: Sujit Basu, Giovanni Caponetti, Daniel Deaver, Katharina Elbert, Jeffrey Hrkach, Michael Lipp